|
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
|
Mar 2021
|
Leukemia
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria
|
Mar 2021
|
Blood cells, molecules and diseases
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management"
|
Mar 2021
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Germline mutations in MDS/AML predisposition disorders
|
Mar 2021
|
Current opinion in hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
|
Feb 2021
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes
|
Feb 2021
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
|
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
|
Feb 2021
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology
|
myelodysplastic syndromes (MDS)
|
|
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantat
|
Feb 2021
|
Journal for immunotherapy of cancer
|
myelodysplastic syndromes (MDS)
|
|
Detectable mutations precede late myeloid neoplasia in aplastic anemia
|
Feb 2021
|
Haematologica
|
aplastic anemia
|
|
Luspatercept in the treatment of lower-risk myelodysplastic syndromes
|
Jan 2021
|
Future Oncology (London, England)
|
myelodysplastic syndromes (MDS)
|
